Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI)
$0.40
-0.0126 ( -3.02% ) 98.6K
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
Market Data
Open
$0.40
Previous close
$0.42
Volume
98.6K
Market cap
$32.56M
Day range
$0.40 - $0.43
52 week range
$0.13 - $1.95
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 22 | Jun 28, 2024 |
8-k | 8K-related | 14 | Jun 26, 2024 |
4 | Insider transactions | 1 | Jun 25, 2024 |
3 | Insider transactions | 1 | Jun 25, 2024 |
8-k | 8K-related | 14 | Jun 20, 2024 |
8-k | 8K-related | 13 | Jun 04, 2024 |
4 | Insider transactions | 1 | Jun 03, 2024 |
4 | Insider transactions | 1 | May 23, 2024 |
10-q | Quarterly Reports | 51 | May 14, 2024 |
4 | Insider transactions | 1 | May 14, 2024 |